<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Somaxon Pharmaceuticals Inc.</title><link href="http://guidetoinsomnia.com/topic/somaxon-pharmaceuticals-inc" rel="alternate"></link><id>http://guidetoinsomnia.com/topic/somaxon-pharmaceuticals-inc</id><updated>2010-10-25T11:27:18Z</updated><entry><title>Somaxon Will Do More Than Just Collect Checks in P&amp;G Deal</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-collect-checks-pg-deal-1380063a" rel="alternate"></link><updated>2010-09-11T18:27:15Z</updated><author><name>SeekingAlpha</name></author><id>tag:guidetoinsomnia.com,2010-09-11:/insomnia/somaxon-collect-checks-pg-deal-1380063a/</id><summary type="html">...</summary><category term="Family Medicine"></category><category term="Insomnia"></category><category term="Insurance Industry"></category><category term="Insurance Carriers"></category><category term="Health and Medical Insurance Carriers"></category><category term="Health Care Plans"></category><category term="United States"></category><category term="Cincinnati"></category><category term="California"></category><category term="Food and Drug Administration"></category><category term="The Procter &amp; Gamble Company"></category><category term="Ambien"></category><category term="Lunesta"></category><category term="Prilosec"></category><category term="Warner Chilcott plc"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Jeffrey Raser"></category></entry><entry><title>Somaxon, Procter &amp; Gamble co-promote insomnia drug</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-procter-gamble-copromote-insomnia-drug-1028839a" rel="alternate"></link><updated>2010-08-25T05:45:19Z</updated><author><name>AP News</name></author><id>tag:guidetoinsomnia.com,2010-08-25:/insomnia/somaxon-procter-gamble-copromote-insomnia-drug-1028839a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Somaxon Pharmaceuticals Inc." href="/topic/Somaxon+Pharmaceuticals+Inc." &gt;Somaxon&lt;/a&gt;, Procter &amp;amp; Gamble agree to co-promote new insomnia drug &lt;a title="Silenor" href="/topic/Silenor" &gt;Silenor&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Somaxon Pharmaceuticals Inc. will team with Procter &amp;amp; &lt;a title="Gamble" href="/topic/Gamble" &gt;Gamble Co.&lt;/a&gt; to co-promote the insomnia treatment Silenor to thousands of doctors and pharmacies.&lt;/p&gt;&lt;p&gt;The companies will combine sales forces to target 35,0...</summary><category term="Insomnia"></category><category term="United States"></category><category term="Cincinnati"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="Gamble"></category><category term="Prilosec"></category><category term="Warner Chilcott plc"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category></entry><entry><title>Somaxon Pharmaceuticals Announces Silenor Co-Promotion Agreement with Procter &amp; Gamble</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-pharmaceuticals-announces-silenor-copromotion-agreement-procter-gamble-1371780a" rel="alternate"></link><updated>2010-09-11T13:23:38Z</updated><author><name>Drugs.com</name></author><id>tag:guidetoinsomnia.com,2010-09-11:/insomnia/somaxon-pharmaceuticals-announces-silenor-copromotion-agreement-procter-gamble-1371780a/</id><summary type="html">...</summary><category term="Insomnia"></category><category term="United States"></category><category term="U.S. Securities and Exchange Commission"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="The Procter &amp; Gamble Company"></category><category term="Publicis Groupe SA"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Thomas Finn"></category><category term="Securities Exchange Act"></category><category term="Eastern Somaxon Pharmaceuticals Inc."></category><category term="Richard Pascoe"></category></entry><entry><title>Somaxon share offering to fund insomnia drug plan</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-share-offering-fund-insomnia-drug-plan-882344a" rel="alternate"></link><updated>2010-09-22T14:21:36Z</updated><author><name>AP News</name></author><id>tag:guidetoinsomnia.com,2010-09-22:/insomnia/somaxon-share-offering-fund-insomnia-drug-plan-882344a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Somaxon Pharmaceuticals Inc." href="/topic/Somaxon+Pharmaceuticals+Inc." &gt;Somaxon&lt;/a&gt; to sell 4 million shares to raise funds for marketing insomnia drug &lt;a title="Silenor" href="/topic/Silenor" &gt;Silenor&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Just days after receiving &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; approval for Silenor, biotech company Somaxon Pharmaceuticals Inc. made plans to sell 4 million shares to f...</summary><category term="Financial Markets"></category><category term="Stock Offerings"></category><category term="Stock Prices"></category><category term="Insomnia"></category><category term="Food and Drug Administration"></category><category term="Oppenheimer Holdings Inc."></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Stock Markets"></category></entry><entry><title>Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-announces-fda-approval-silenor-doxepin-treatment-insomnia-3147835a" rel="alternate"></link><updated>2010-10-25T11:27:18Z</updated><author><name>Drugs.com</name></author><id>tag:guidetoinsomnia.com,2010-10-25:/insomnia/somaxon-announces-fda-approval-silenor-doxepin-treatment-insomnia-3147835a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Insomnia"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="United States"></category><category term="U.S. Securities and Exchange Commission"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="U.S. Drug Enforcement Administration"></category><category term="National Sleep Foundation"></category><category term="Henry Ford Health System"></category><category term="Robert Jaffe"></category><category term="Thomas Roth"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Securities Exchange Act"></category><category term="Richard Pascoe"></category><category term="PondelWilkinson Inc."></category><category term="Rob Whetstone"></category></entry><entry><title>Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-pharmaceuticals-fda-close-decision-silenor-2769447a" rel="alternate"></link><updated>2010-10-22T12:57:35Z</updated><author><name>SeekingAlpha</name></author><id>tag:guidetoinsomnia.com,2010-10-22:/insomnia/somaxon-pharmaceuticals-fda-close-decision-silenor-2769447a/</id><summary type="html">...</summary><category term="Allergies"></category><category term="Insomnia"></category><category term="Mental Health"></category><category term="Mood Disorders"></category><category term="Depression"></category><category term="United States"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="National Sleep Foundation"></category><category term="Doxepin"></category><category term="Ambien"></category><category term="Lunesta"></category><category term="Clinical Immunology"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Transcept Pharmaceuticals Inc."></category><category term="Brain and Nerve Health"></category></entry><entry><title>Somaxon Pharmaceuticals Presents Analyses of Silenor Clinical Data at the American Psychiatric Association Annual Meeting</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-pharmaceuticals-presents-analyses-silenor-clinical-data-american-psychiatric-association-annual-meeting-3009935a" rel="alternate"></link><updated>2010-10-24T09:14:33Z</updated><author><name>Drugs.com</name></author><id>tag:guidetoinsomnia.com,2010-10-24:/insomnia/somaxon-pharmaceuticals-presents-analyses-silenor-clinical-data-american-psychiatric-association-annual-meeting-3009935a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Insomnia"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="San Francisco"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="American Psychiatric Association"></category><category term="National Sleep Foundation"></category><category term="Doxepin"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category></entry><entry><title>Somaxon Presents Pharmacological Data on Doxepin at the 21st European College of Neuropsychopharmacology Congress</title><link href="http://guidetoinsomnia.com/insomnia/somaxon-presents-pharmacological-data-doxepin-21st-european-college-neuropsychopharmacology-congress-2948473a" rel="alternate"></link><updated>2010-10-23T15:59:48Z</updated><author><name>Drugs.com</name></author><id>tag:guidetoinsomnia.com,2010-10-23:/insomnia/somaxon-presents-pharmacological-data-doxepin-21st-european-college-neuropsychopharmacology-congress-2948473a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Insomnia"></category><category term="Mental Health"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="U.S. Securities and Exchange Commission"></category><category term="San Diego"></category><category term="Food and Drug Administration"></category><category term="Doxepin"></category><category term="Sleeping and Sleep Disorders"></category><category term="Silenor"></category><category term="Somaxon Pharmaceuticals Inc."></category><category term="Securities Exchange Act"></category><category term="European College of Neuropsychopharmacology"></category><category term="Philip Jochelson"></category><category term="ECNP Congress"></category></entry></feed>
